Skip to main content
SpringerLink
Log in

Comment on ‘What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain: Expert Opinion’

  • Letter to the Editor
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Davies AN, Dickman A, Reid C. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain. 2009;13(4):331–8.

    Article  PubMed  Google Scholar 

  2. Portenoy RK, Hagen NA. Breakthrough pain: definition and management. Oncology (Willison Park NY). 1989;3(8 Suppl):25–9.

    CAS  Google Scholar 

  3. Working Group Nientemale DEI, Vellucci R, Fanelli G, Pannuti R, Peruselli C, Adamo S, Alongi G, Amato F, Consoletti L, Lamarca L, Liguori S, Lo Presti C, Maione A, Mameli S, Marinangeli F, Marulli S, Minotti V, Miotti D, Montanari L, Moruzzi G, Palermo S, Parolini M, Poli P, Tirelli W2, Valle A, Romualdi P. What to do, and what not to do, when diagnosing and treating breakthrough cancer pain (BTcP). Expert Opin Drugs. 2016;76(3):315–30.

  4. Lee TH. Zero pain is not the goal. JAMA. Published online March 15, 2016. doi:10.1001/jama.2016.1912.

  5. Zeppetella G, Davies AN. Opioids for the management of breakthrough pain in cancer patients. In: Cochrane Database of Systematic Reviews. Wiley;2015. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004311.pub4/abstract. Accessed 21 Mar 2016.

  6. Ruiz-Garcia V, Lopez-Briz E. http://www.bmj.com/content/337/bmj.a3104/rr. Accessed 21 Mar 2016.

  7. Watson M. Back to the future, current trends in breakthrough pain treatments. Indian J Palliative Care. 2011;17(Suppl):S26–8.

    Article  Google Scholar 

  8. Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D. Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J Clin Oncol. 2016. doi:10.1200/JCO.2015.63.2232.

    PubMed  Google Scholar 

  9. Løhre ET, Klepstad P, Bennett MI, Brunelli C, Caraceni A, Fainsinger RL, Knudsen AK, Mercadante S, Sjøgren P, Kaasa S; European Association for Palliative Care Research Network. From “breakthrough” to “episodic” cancer pain? A European Association for Palliative Care Research Network Expert Delphi Survey Toward a Common Terminology and Classification of Transient Cancer Pain Exacerbations. J Pain Symptom Manage. 2016;51(6):1013–9. doi:10.1016/j.jpainsymman.2015.12.329.

  10. Boceta J, De la Torre A, Samper D, Farto M, Sánchez-de la Rosa R. Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study. Clin Transl Oncol. 2016. doi:10.1007/s12094-016-1490-4.

  11. Mercadante S, Marchetti P, Cuomo A, Mammucari M. Caraceni A; IOPS MS study Group. Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group. Support Care Cancer. 2016;24(2):961–8.

    Article  PubMed  Google Scholar 

  12. Porta-Sales J, Pérez C, Escobar Y, Martínez V. Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON). Clin Transl Oncol. 2015. doi:10.1007/s12094-015-1468-7.

  13. Bedard G, Davies A, McDonald R, Hawley P, Buchanan A, Popovic M, Wong E, Chow E. Breakthrough cancer pain: a comparison of surveys with European and Canadian patients. Support Care Cancer. 2015;23(3):791–6.

    Article  PubMed  Google Scholar 

  14. Bedard G, Hawley P, Zhang L, Slaven M, Gagnon P, Bisland S, Bennett M, Tardif F, Chow E. A survey of Canadian cancer patients’ perspectives on the characteristics and treatment of breakthrough pain. Support Care Cancer. 2013;21(9):2557–63.

    Article  PubMed  Google Scholar 

  15. American Pain Foundation. Breakthrough cancer pain: mending the break in the continuum of care. J Pain Palliat Care Pharmacother. 2011;25(3):252–64.

    Article  CAS  PubMed  Google Scholar 

  16. Davies AN. The management of breakthrough cancer pain.Br J Nurs. 2011;20(13):803–4, 806–7.

  17. Dickman A. Integrated strategies for the successful management of breakthrough cancer pain. Curr Opin Support Palliat Care. 2011;5(1):8–14.

    Article  PubMed  Google Scholar 

  18. Greco MT, Corli O, Montanari M, Deandrea S, Zagonel V. Apolone G; Writing Protocol Committee; Cancer Pain Outcome Research Study Group (CPOR SG) Investigators. Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients: results from the Cancer Pain Outcome Research Study Group. Clin J Pain. 2011;27(1):9–18.

    Article  PubMed  Google Scholar 

  19. Mercadante S, Villari P, Casuccio A. An Italian survey on the attitudes in treating breakthrough cancer pain in hospice. Support Care Cancer. 2011;19(7):979–83.

    Article  PubMed  Google Scholar 

  20. Jacobsen R, Møldrup C, Christrup L. Clinical rationale for administering fentanyl to cancer pain patients: two Delphi surveys of pain management experts in Denmark. J Opioid Manag. 2008;4(6):383–91.

    PubMed  Google Scholar 

  21. Soares LG, Chan VW. The rationale for a multimodal approach in the management of breakthrough cancer pain: a review. Am J Hosp Palliat Care. 2007;24(5):430–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Oncology Unit, Sant’Andrea Hospital of Rome, Via di Grottarossa 1035-39, 00189, Rome, Italy

    Raffaele Giusti & Daniela Iacono

  2. Medical Oncology Unit, University of L’Aquila, L’Aquila, Italy

    Lucilla Verna, Corrado Ficorella & Giampiero Porzio

  3. Associazione Tumori Toscana, Home Care Service, Florence, Italy

    Lucilla Verna, Agnese Vannini & Giampiero Porzio

Authors
  1. Raffaele Giusti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lucilla Verna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniela Iacono
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Agnese Vannini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Corrado Ficorella
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giampiero Porzio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raffaele Giusti.

Ethics declarations

Funding

No funding was received.

Conflict of interest

The authors declare that they have no conflict of interest related to this letter.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giusti, R., Verna, L., Iacono, D. et al. Comment on ‘What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain: Expert Opinion’. Drugs 76, 1059–1061 (2016). https://doi.org/10.1007/s40265-016-0593-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40265-016-0593-0

Keywords

Search

Navigation